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Keratinanimal embryos, superﬁcial cells of the blastula form a distinct lineage and adopt
an epithelial morphology. In different animals, the fate of these primary superﬁcial epithelial (PSE) cells
varies, and it is unclear whether pathways governing segregation of blastomeres into the PSE lineage are
conserved. Mutations in the gene encoding Interferon Regulatory Factor 6 (IRF6) are associated with
syndromic and non-syndromic forms of cleft lip and palate, consistent with a role for Irf6 in development of
oral epithelia, and mouse Irf6 targeted null mutant embryos display abnormal differentiation of oral epithelia
and skin. In Danio rerio (zebraﬁsh) and Xenopus laevis (African clawed frog) embryos, zygotic irf6 transcripts
are present in many epithelial tissues including the presumptive PSE cells and maternal irf6 transcripts are
present throughout all cells at the blastula stage. Injection of antisense oligonucleotides with ability to
disrupt translation of irf6 transcripts caused little or no effect on development. By contrast, injection of RNA
encoding a putative dominant negative Irf6 caused epiboly arrest, loss of gene expression characteristic of the
EVL, and rupture of the embryo at late gastrula stage. The dominant negative Irf6 disrupted EVL gene
expression in a cell autonomous fashion. These results suggest that Irf6 translated in the oocyte or
unfertilized egg sufﬁces for early development. Supporting the importance of maternal Irf6, we show that
depletion of maternal irf6 transcripts in X. laevis embryos leads to gastrulation defects and rupture of the
superﬁcial epithelium. These experiments reveal a conserved role for maternally-encoded Irf6 in
differentiation of a simple epithelium in X. laevis and D. rerio. This epithelium constitutes a novel model
tissue in which to explore the Irf6 regulatory pathway.
© 2008 Elsevier Inc. All rights reserved.IntroductionOne of the ﬁrst examples of cell diversiﬁcation during embryogen-
esis occurs during the blastula stage, when superﬁcial cells adopt an
epithelial morphology and become a distinct lineage. These cells form
a tight, simple epithelium around the embryo that serves to protect it,
to regulate osmotic balance, and to provide mechanical support
necessary for early morphogenesis (Regen and Steinhardt, 1986; Zalik
et al., 1999). In D. rerio this layer is referred to as the enveloping layer
(EVL), in X. laevis as the primary or superﬁcial epithelium (SE), and incted at Department of Biology,
ll Department of Anatomy and
wa, Iowa City, IA 52242, USA.
. Houston),
enetics and Pediatrics, 5150
, East Lansing, MI, USA.
l rights reserved.mammals as trophectoderm (TE). We refer to this layer in general as
the primary superﬁcial epithelium (PSE). In each of these taxa, PSE
layers form a distinct lineage, but the fate of PSE cells varies among
species. In D. rerio the sole fate of the EVL is to become periderm
(Kimmel et al., 1990), an embryonic skin that is shed as the underlying
epidermis matures (shown in trout) (Bouvet, 1976). In X. laevis, ventral
PSE cells contribute to the superﬁcial layer of the skin that may also
eventually be shed (Chalmers et al., 2006), while dorsal PSE cells are
incorporated into the neural tube as secondary neuronal precursors
(Hartenstein, 1989). In mammals the PSE contributes to the placenta
and other extra-embryonic membranes, which are structures that do
not form in D. rerio and X. laevis. Thus PSE cells in different species
share the general features of having a simple epithelial architecture
and of segregating early from other lineages, but yet have distinct
fates.
Because PSE cells adopt different fates in different species, it is
unclear whether mechanisms governing segregation of the PSE
250 J.L. Sabel et al. / Developmental Biology 325 (2009) 249–262lineage from underlying blastomeres are conserved among animals. In
X. laevis, cell division planes predict which daughters of a PSE cell will
remain in the PSE and which will join deeper layers of ectoderm,
arguing that unequal segregation of cell components contributes to
the choice between PSE and deep cell fates (Chalmers et al., 2003). The
polarity of X. laevis SE cells is regulated by atypical Protein Kinase C
(aPKC), partition defective 1 (PAR1), Lethal giant larvae and Scribble,
all members of the widely-conserved PAR/aPKC polarity pathway
(Chalmers et al., 2005; Dollar et al., 2005; Suzuki and Ohno, 2006).
aPKC is localized to the egg cortex and later to the apical side of PSE
cells (Chalmers et al., 2003; Nakaya et al., 2000). Forced expression of
aPKC can drive deep cells to express markers of the PSE fate, which
suggests inheritance of aPKC is a determinant of PSE fate (Ossipova et
al., 2007). PAR1 is basally localized in PSE cells and likely serves as a
determinant of the deep blastomere fate (Ossipova et al., 2007). In
mouse embryos, after an initial period where cells can change fate
after rearrangement, cells become polarized, and, as in X. laevis,
apically-localized aPKC appears to promote the trophectoderm fate
(Johnson and McConnell, 2004). In D. rerio it is unknownwhether the
aPKC/PAR pathway contributes to commitment of cells to the PSE.
However, lineage studies revealed that after about 4 hpf, deep layer
blastomeres do not intercalate into the PSE, and conversely daughters
of EVL cells remain within the EVL (Kimmel et al., 1990). Transplant
studies indicated that PSE cells become committed to an epithelial
morphology at around 5 h post fertilization (hpf) because they will do
so even when transplanted into the deep layer (DEL) of blastomeres
(Ho, 1992). When EVL and DEL of animal pole explants are separated,
DEL cells do not gain expression of EVL markers, or do so at a very low
level (Sagerstrom et al., 2005). Together these ﬁndings are consistent
with the possibility that inheritance of egg membrane components is
required to specify PSE fate in D. rerio.
The transcription factors that act downstream of aPKC, or other
inherited determinants, to promote PSE development have not been
well characterized. A candidate transcription factor to regulate PSE
development is Interferon Regulatory Factor 6 (Irf6) because it is
implicated in differentiation of several other epithelial tissues. IRFs are
a family of transcription factors with a shared structure including an
amino-terminal DNA binding domain and a carboxy-terminal domain
that mediates homo and heterodimerization called the Interferon
Association Domain (IAD). For most IRF family members, a pathogenic
stimulus leads to phosphorylation of the IAD, stimulating nuclear
translocation, dimerization, and activation of transcription from target
genes including interferon genes (reviewed in Paun and Pitha, 2007).
IRF6 by contrast plays no role in innate immunity but is essential for
embryonic development. Genetic variation in IRF6 is associated with
syndromic and non-syndromic forms of cleft lip and palate (Kondo et
al., 2002a; Zucchero et al., 2004), possibly reﬂecting a role in the
epithelia covering palatal shelves, where it is expressed at high levels
(Knight et al., 2006; Kondo et al., 2002b). Mouse embryos homo-
zygous for targeted mutations in Irf6 display defects in differentiation
of keratinocytes, and exhibit adhesions between the tongue and
maxillary prominence, suggesting a defect in differentiation of oral
epithelia (Ingraham et al., 2006; Richardson et al., 2006). IRF6 is
expressed in breast epithelial cells where it may regulate the decision
to divide vs. differentiate (Bailey et al., 2008a, 2005). However it is
unknown whether Irf6 function in epithelial development extends to
the PSE.
Here we report that in D. rerio and X. laevis embryos at blastula
stage, irf6 mRNA is present in both deep and superﬁcial layers of
blastomeres, and that interfering with maternal Irf6 causes epiboly
arrest concomitant with a gross failure of PSE development. Thus,
expressing a dominant negative variant of Irf6 in D. rerio, or depleting
maternal irf6 transcripts in X. laevis embryos, causes PSE cells to lose
characteristic gene expression. We show that the requirement for Irf6
for PSE cell differentiation is cell autonomous. Overall, these data
demonstrate a critical role for Irf6 in simple epithelia, and underscorethe utility of studying PSE as a model epithelium to explore the Irf6
regulatory pathway.
Materials and methods
Danio rerio maintenance
Breeding D. reriowere maintained as described (Westerﬁeld, 1993)
in the University of Iowa Animal Care Facility. Embryos were staged
according to Kimmel et al. at 28.5 °C by hours or days post fertilization
(hpf or dpf) (Kimmel et al., 1995).
Isolation of irf6 clones and plasmid construction
The D. rerio cDNA clone for an EST corresponding to irf6
(GenBank accession number AW422721. Full length cDNA,
AY725802, Ben et al., 2005) was purchased from Research Genetics
(Invitrogen). Bi-directional DNA sequencing was performed across
the entire cDNA insert using gene speciﬁc primers. Plasmids for
mRNA production were prepared as follows: irf6 cDNA correspond-
ing to the full open reading frame (Irf6ORF, for rescue experiments),
or to only the DNA binding domain, i.e. amino acids 1–115, (for
construction of Irf6DBD), was inserted into the pCS2+ vector or the
pCS2+MT vector, respectively. For use in testing the efﬁcacy of
translation blocking MO, irf6 cDNA corresponding to most of the 5′
untranslated region (excluding the initial 85 bases of 279 bases total
in order to remove two start codons in an alternative open reading
frame) plus the irf6 open reading frame were inserted in the C2+MT
vector, yielding a transcript that encodes Irf6 with 6 Myc epitopes
on the carboxy terminus. Two X. laevis irf6 orthologues have been
identiﬁed which we refer to as irf6.1 (previously called irf-6,
GenBank accession number D86492, Hatada et al., 1997), and irf6.2
(GenBank accession number BC071111, Klein et al., 2002). An irf6.2
plasmid was obtained commercially (Open Biosystems, Huntsville,
AL) and veriﬁed by sequencing. The coding sequencewas ampliﬁed by
PCR, cloned into pCR8-GW-TOPO and sub-cloned into a custom
Gateway-compatible (Invitrogen) pCS2+ vector for expression studies.
Morpholino and mRNA injections — Danio
Three translation blocking morpholinos (MO), targeting the start
codon or the 5′ untranslated region (5′ UTR) of D. rerio irf6 (ZGC
Clone BC056772.1, zgc.nci.nih.gov) and two splice-blocking morpho-
linos, targeting splice sites, were ordered (Gene Tools, Philomath,
OR) (splice sites from Ensembl gene ENSDARG00000043296).
Sequence of MO is as follows: irf6 AUG: ATGAGACGACATCA-
CACCGGCTGAG; irf6 5′utr: GGCTCAAAGCAGGAAAAGGCAGCAC; irf6
5′utr-b: GCCTTTGCCGCCAAAACGAACGGTT; irf6 exon 2/intron 2 (e2/
i2): TTCTGACCTTAAAGATGGTGTTCTC; irf6 intron 3/exon 4 (i3/e4):
GAACTGAACCTGAAGTAGAGCATTA. To test the ability of irf6 splice-
blocking MO to disrupt normal splicing of irf6 mRNA, RNA was
collected with Trizol, following manufacturers instructions (Invitro-
gen), at 20 hpf from embryos injected at the 2-cell stage with 5 ng
of MO. First strand cDNA was generated with random hexamers as
described previously (O'Brien et al., 2004). To check efﬁcacy of e2i2
MO by PCR, a forward PCR primer in exon 1 and a reverse primer in
exon 3 were used, for i3/e4 MO, primers in exon 1 and exon 5 were
used. An MO targeting p53 and the standard negative control MO
from Gene Tools were injected at 5 ng/embryo. MO were diluted to
5 mg/ml in Danieau solution (Nasevicius and Ekker, 2000) for
storage at −20 °C and diluted before use to 1 mg/ml in 0.2 M KCl.
Embryos were injected with MO into the yolk beneath the
blastomeres at the 1–4 cell stage. Template DNA was prepared by
linearization and cleaned of histones by Proteinase K digestion
followed by phenol extraction. Capped RNA synthesis, using SP6,
was carried out using the mMessage mMachine (Ambion, Austin,
251J.L. Sabel et al. / Developmental Biology 325 (2009) 249–262TX) transcription. RNA was recovered with Microcon microconcen-
trators (Millipore, Billerica, MA).
In Danio experiments, mRNA was injected into the cytoplasm at
the 1-cell stage for global injections, into the cytoplasm of a single cell
at the 16–32-cell stage for mosaic injections, and into the yolk after
sphere stage (4 hpf) for YSL injections. Sytox green (Invitrogen) was
co-injected in YSL injections for labeling yolk syncytial nuclei. The
high dose, used in all experiments herein except as noted was 3 ng
mRNA/embryo in global injections. Low dose, total of 1.2 ng RNA/
embryo. These RNA doses are about 10 times higher than those
required to observe speciﬁc phenotypes with another dominant
negative transcription factor in D. rerio (dlx3, Kaji and Artinger, 2004),
although in the latter case, a constitutive repressor domain was fused
to the DNA binding domain, whichmay have improved its efﬁcacy as a
dominant negative. Importantly, embryos injectedwith 3 ng of control
RNAs encoding GFP or beta galactosidase developed normally.
Histology
An anti-cMyc antibody (Santa Cruz Biotechnology, Santa Cruz, CA)
was used in whole-mount immunohistochemistry as previously
described (O'Brien et al., 2004). This antibody was also used in
combination with DIG-labeled zfk8 RNA probes in whole mount double
labeling as previously described (Cornell and Eisen, 2000). Cell death by
apoptosis was monitored by terminal transferase dUTP nick-end
labeling in whole embryos as previously described (Li and Cornell,
2007). To label polymerized actin, embryos were ﬁxed at the shield
stage for 48 h in 4% PFA, rinsed in PBS+0.1% Tween 20 (PBST), incubated
for 1 h in 0.165 M Phalloidin Alexa 546 (U. Iowa Central Microscopy
Research Facility, Iowa City, IA), washedwith PBST, and visualizedwith a
Texas Red ﬁlter. Sytox green (Invitrogen)was used to label yolk syncytial
nuclei and was injected into the yolk of live embryos after the sphere
stage (4 hpf) as described (D'Amico and Cooper, 2001). Alcian greenwas
used to label cartilage in 4 dpf embryos that were ﬁxed in 4% PFA for
24 h as described (Kimmel et al.,1998). For thick sections, embryos ﬁxed
in 4% PFAwere embedded in 1.5% agar, soaked in 30% sucrose overnight,
and sectioned on a Jung Frigocut 2800 cryostat (Leica, Wetzlar,
Germany) to a thickness of 14–16 μm.
Probes for in situ hybridization were generated for irf6, cebpb and
gsc genes by RT-PCR (primer sequences are available upon request).
Fragments were inserted into the pCR4TOPO vector (Invitrogen).
Plasmids were linearized, and DIG-labeled antisense RNA probes
transcribed (Roche Diagnostics, Mannheim, Germany) as follows: irf6,
(PstI/T7); cebpb, (NotI/T3); gsc, (NotI/T3). Alternatively, probes were
linearized and transcribed from existing plasmids as follows: tfap2a
(O'Brien et al., 2004), NotI/T7; zfk8 (Imboden et al., 1997), Asp718/SP6;
gata2 (Detrich et al., 1995), XbaI/SP6; ntl (Schulte-Merker et al., 1994),
SalI/T7; sox2 (Li and Cornell, 2007); krt18 (Pei et al., 2007), NotI/SP6;
k4, (Pei et al., 2007), Not1/SP6.
Immunostaining and whole-mount in situ hybridization — Xenopus
Embryos for immunostaining were devitellined and ﬁxed in
methanol at −20 °C. Samples were embedded, sectioned and
immunostained with mAb LP3K (a gift from Birgitte Lane, see Lane
et al., 1985) as described (Godsave et al., 1984). Secondary antibodies
were Alexa-488 conjugated goat anti-mouse antibodies (Invitrogen/
Molecular Probes). Azan staining was done as previously described
(Houston and King, 2000).
Whole-mount in situ hybridization was performed essentially as
described (Sive et al., 2000), with replacement of the triethanolamine
and acetic anhydride washes by a single 20 minute wash in 0.1% active
DEPC in PBS (after Braissant and Wahli, 1998). The probe for intelectin
2 (XL020e14) was identiﬁed through the work of Hayes et al. (2007)
and obtained through the NIBB/NIG/NBRP Xenopus laevis EST project
(Hayes et al., 2007). Antisense probes were made by linearizingplasmid templates with EcoRI, followed by transcription with T7 RNA
polymerase.
In situ hybridization on parafﬁn sections was performed essen-
tially as described (Butler et al., 2001). Irf6 antisense probes were
prepared from a full-length clone in pCMVSPORT6 by linearizing with
SalI and transcribing with T7.
Microscopy — Danio
D. rerio images were documented on a DMRA 2 compound
microscope or a MZ FLIII stereo-microscope (Leica, Wetzlar, Germany).
Images were captured with a Retiga 1300 camera (Q-Imaging,
Burnaby, Canada) and Openlab software (Improvision, Lexington,
MA). Labeling and contrast adjustments were done in Photoshop 7.0
(Adobe, San Jose, CA).
Xenopus oocytes, embryos and explants
Ovary was isolated from mature X. laevis females, subdivided into
small segments, and stored at 18 °C in oocyte culture medium (OCM;
70% L-15, 0.04% BSA, 1 mM Glutamax (Invitrogen), 1.0 μg/ml
gentimicin, pH 7.6–7.8), modiﬁed from Heasman et al (1991). Oocytes
were isolated by manual defolliculation and cultured in OCM and
oocyte maturation was induced by the addition of 2.0 μM progester-
one. Ovulated eggs from females induced with human chorionic
gonadotropin (hCG) were fertilized in vitro using a sperm suspension
and placed in 0.1× MMR (1× MMR: 0.1 M NaCl, 1.8 mM KCl, 2.0 mM
CaCl2, 1.0 mM MgCl2, 15.0 mM HEPES, pH 7.6). Jelly coats were
removed in cysteine (2% in 0.1× MMR, pH 7.8). For isolation of
superﬁcial and deep layers, animal caps were dissected at stage 9 in
calcium–magnesium-free MMR and transferred to 67 mM phosphate
buffer (pH 7.2) for 3 min. The caps were then transferred to fresh
calcium–magnesium-free MMR+0.1% BSA and incubated for 10 min,
after which the superﬁcial layer was gently teased away from deep
cells using a tungsten needle. Blastomeres in the deep cell layer
became loosely adhering, but were never fully disaggregated during
the procedure. The layers were cultured separately in OCM, which
contains calcium, until the desired stage.
Antisense oligos and host-transfer — Xenopus
AnMOwas designed to complement the X. laevis irf6mRNA 5′ UTR
and start codon. This sequence is expected to target both identiﬁed
irf6 orthologues. Although there is a one-base mismatch with irf6.2,
this difference is not predicted to alter the binding of the MO. (irf6-
MO; 5′-GTGCATAGCCATGACCTCTGCCTGG -3′, Gene-Tools). The pre-
dicted start codon is underlined. Morpholinos were dissolved in
nuclease-free water to 1 mM and stored at −80 °C. Manually
defolliculated stage VI oocytes were injected animally with 24 ng of
irf6-MO and maintained in OCM at 18 °C for 24–48 h prior to
maturation with progesterone. Oocytes were stimulated to mature
approximately 10–12 h prior to implantation into laying host females
(Heasman et al., 1991). Oocytes were injected while in OCM; embryos
were injected in Ficoll solution (2% Ficoll, 0.5× MMR, pH 7.8).
RT-PCR — Xenopus
Embryos and explants for RT-PCR analysis were frozen on dry ice
and stored at −80 °C. Samples were homogenized in 200 μl of RNA
lysis buffer per embryo, DNase I treated, subjected to RT-PCR and
analyzed either by gel or by quantitative PCR, essentially as
described (Houston and King, 2000; Houston and Wylie, 2005).
Real time PCR was performed on a LightCycler 480 machine (Roche
Applied Science). Relative expression values for quantitative RT-PCR
were determined by comparison to a standard curve of serially
diluted cDNA from uninjected controls, followed by normalization to
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individual experiments using unreplicated samples, but were
repeated at least twice with similar results. Primer sequences and
detailed protocols are available upon request.
Western blots
60 embryos at the 1–2 cell stage were injected with 1 ng of irf6mt
RNA. At the 2–4 cell stage, 20 of the previously RNA injected embryos
were injected a second time with approximately 5 ng of irf6 AUG MO,
and 20 with approximately 6 ng of irf6 5′ UTR MO. At the shield stage
(6 hpf) embryos were frozen at −80 °C. Frozen embryos were thawed
and diluted in 5 ml loading buffer per embryo. Three embryo
equivalents were run on a pre-cast 10% Tris HCL protein gel (Bio-Rad
Laboratories) for 105 min at 100 V. The protein was transferred to a
nitrocellulosemembrane for 1 h at 400mA. Themembranewas blocked
in milk blocking buffer for 1 h and then probed with mouse anti-Myc
antibody (9E10, Santa Cruz Biotechnology, Santa Cruz, CA) diluted
1:1500 in blocking buffer (Phosphate buffered solution (PBS), 0.15 M
NaCl, 0.1% Tween 20, 0.04 g/ml dried milk) overnight at 4 degrees. The
membrane was washed in blocking buffer and then probed with anti-
mouse IR800 secondary antibody (Rockland Immunochemicals, Gil-
bertsville, PA) diluted 1:10,000 in blocking buffer for 1 h at RT. The
membrane was washed with blocking buffer and then PBS and imaged
with the Odyssey system (LI-COR Biosciences, Lincoln, NE).Fig. 1. Danio rerio irf6 expression by in situ hybridization. Lateral views, except as indicated, of
except B and inset in C. (A) A cleavage stage embryo, revealing high-level maternal expressio
background staining. (C) Section at shield stage showing low-level expression in deep cells (D
of a shield stage embryo processed with a sense probe. (D) Diffuse expression throughout the
to the left in panels D–F. (E) Decreasing diffuse expression, expression present in nasal and
including putative gut precursor cells (arrowhead). (G) Ventral view, showing expression
(asterisk) (e, eye). H) Expression in pharyngeal pouches (arrowhead) and ear (asterisk). (I) H
expression in pharyngeal pouches (arrowheads). (e, eye).Results
D. rerio irf6 expression
To investigate the function of Irf6 in D. rerio, we searched D. rerio
cDNA and genomic DNA sequence databases and detected a single
orthologue of mammalian IRF6. By whole mount in situ hybridization
we observed irf6 expression in cleavage-stage embryos (Fig. 1A) and
conﬁrmed the presence of maternal irf6 message with semi-quantita-
tive PCR on cDNA generated from fertilized eggs (data not shown).
Sections of 6 hpf embryos revealed diffuse irf6 transcripts in cells of the
deep layer, and higher level expression in EVL and dorsal forerunner
cells (DFC) (Fig. 1C). Diffuse expression remained throughout the
embryo at 13 hpf, but was no longer detectable by 24 hpf (Figs. 1D–F).
Starting at 13 hpf, irf6 expression was observed in many epithelial
structures, including nasal and otic placodes, semi-circular canals, and
oral epithelium (Figs. 1D–J). Expression of irf6 was not detected in
embryonic skin (Fig. 1G). Our independent analysis of D. rerio irf6
expression matches an earlier published report (Ben et al., 2005).
A. putative dominant negative Irf6 disrupts gastrulation
To examine the role of zygotically-expressed Irf6 in early D. rerio
development we injected embryos with a standard dose (5 ng,
Nasevicius and Ekker, 2000) of antisense morpholino oligonucleotidesD. rerio embryos ﬁxed at the indicated stage and processed with an antisense irf6 probe,
n. (B) A cleavage stage embryo, processed with an irf6 sense probe, revealing very little
EL) and higher level expression in EVL and dorsal frontrunner cells (DFC). Inset, section
embryo, with increased expression in the nasal and otic placodes (arrowheads). Head is
otic placodes and lateral line primordium (arrowhead). (F) Expression as in E but now
in pharyngeal pouches (arrowhead). Expression is not detectable in skin at this stage
orizontal section, showing expression in oral epithelium (arrowhead). (J) Ventral view,
253J.L. Sabel et al. / Developmental Biology 325 (2009) 249–262(MO) targeting one or another of two splice sites of the irf6 transcript.
We harvested RNA from MO-injected embryos at 22 h post
fertilization (hpf), synthesized ﬁrst-strand cDNA, and performed PCR
with primers ﬂanking the targeted splice site. Gel analysis followed by
sequencing of theMO-dependent PCR products revealed that bothMOFig. 2. InD. rerio, expression of a putative dominant negative Irf6 causes severe gastrulation d
blocker MO targeting D. rerio irf6. RNA was harvested from 22 hpf embryos that were either
strand cDNAwas synthesized and PCR carried out with forward primer in exon 1 and reverse
and from MO-injected embryo a second, smaller band (arrowhead). The MO-dependent PCR
which encodes the ﬁrst 60 amino acids, including half of the predicted DNA binding domain.
to maternal stores, is spliced correctly (asterisk). −RT, negative control lacking reverse transc
show lysates from 16 hpf embryos injected at the two-cell stage with in vitro transcribed irf6
terminal Myc tag. –, embryos not injected with MO. AUG, RNA-injected embryos subsequentl
5′UTRb MO. In a similar Western blot experiment, embryos injected with 20 ng of a 5-base p
(not shown). (C) Schematics of full-length Irf6 and the DNA binding domain variant, whi
(Taniguchi et al., 2001). (D) Frames from a time-lapse video of a water-injected control, left, a
of the DEL is delayed (most obvious at the animal pole), as is vegetal migration of the DEL (w
the irf6DBD-injected embryo ruptures near the animal pole. Arrowhead indicates ﬁrst area
with equivalent results. (E) Histogram showing percentage of embryos at 24 hpf of the indica
G) Ventral views of 4 dpf embryos stained with alcian-green. (F) Uninjected embryo. (G) irf6
than normal and pectoral ﬁns (arrowheads) are reduced. (H, I) Dorsal views of live, (H) uninj
(arrows) and abnormal ﬁns (arrowheads). (J–M) Lateral views of, (J, L) uninjected and, (K, M)
of zfk8, a marker of the EVL. In the irf6DBD-injected embryo, the vegetal limit of the EVL (arrow
green, revealing that in, M) the irf6DBD-injected embryo vegetal migration of the YSL has saltered splicing of a fraction of irf6 RNA in a manner that would
destroy the encoded protein (Fig 2A and not shown). Because of
defects in skin and craniofacial defects in mouse Irf6 mutants
(Ingraham et al., 2006; Richardson et al., 2006), we anticipated
similar problems in irf6 MO-injected D. rerio embryos. However inefects and late defects in the pectoral ﬁn and skin. (A) RT-PCR analysis of efﬁcacy of splice
uninjected or injected at the single cell stage with 5 ng of irf6 exon 2/intron 2 MO. First
primer in exon 3, yielding, from uninjected embryos (un), a single band of expected size,
product was excised and sequenced and found to reﬂect loss of the ﬁrst coding exon,
In e2i2 MO injected embryos, a substantial fraction of irf6mRNA, possibly corresponding
riptase (B) Western blot analysis of efﬁcacy of MO targeting translation of Irf6. All lanes
RNA altered to include most of the 5′ UTR and to encode full length Irf6 with a carboxy-
y with 5 ng of irf6 AUGMO; 5′UTR, RNA-injected embryos subsequently with 5 ng of irf6
air mismatch variant of the AUGMO were comparable to embryos not injected with MO
ch contains the amino terminal 115 amino acids. IAD, Interferon Association Domain
nd an irf6DBD-injected embryo, right, taken at the indicated times. In the latter, thinning
hite line, extent of DEL migration). Finally, when siblings are at about 80% epiboly (9 h),
of embryo rupture. Staging was analyzed in 10 embryos in three separate experiments
ted class that were normal (black), or dead (red), or with head and tail defects (grey). (F,
DBD-injected embryos showing pharyngeal cartilage elements are present but smaller
ected embryo and, (I) irf6DBD-injected embryos at 4 dpf. The later shows blistered skin
irf6DBD-injected embryos at shield stage. (J, K) Embryos processed to reveal expression
head) is at the position appropriate for dome stage. (L, M) YSL nuclei labeled with sytox
talled at dome stage.
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(dpf) and craniofacial cartilage at 4 dpf, and the overall morphology of
the embryos, were grossly normal (nN100 embryos). Embryos
injected with high doses of these MO (20 ng/embryo) still developed
grossly normally, without defects in skin, pectoral ﬁns, or craniofacial
cartilage (nN100 embryos). A possible explanation for these unex-
pected ﬁndings is the existence of an Irf6 homologue that can
compensate for the reduction of zygotic Irf6 expression; alternatively,
maternally-encoded Irf6 protein serves this function.
To attempt to block translation of maternal irf6 transcripts, we
ordered an MO complementary to the start codon of irf6 mRNA (irf6
AUG MO). To test efﬁcacy of this MO, we injected it into embryos
previously injected with RNA containing the irf6 5′UTR and encoding
a carboxy-terminal Myc-tagged variant of Irf6 (i.e., irf6MT RNA).
Injection of 5 ng or more of this MO efﬁciently blocked translation of
the irf6MT RNA as monitored by Western analysis, while injection of
20 ng of a negative control MO did not block translation (Fig 2B and
not shown). Surprisingly, embryos injected with 5 ng of irf6 AUG MO
developed grossly normally (not shown). To conﬁrm these ﬁndings,
we ordered two additional irf6MO, complementary to distinct parts of
the 5′ UTR and found they gave comparable results to the irf6 AUGMO
(not shown). Of note, it is possible that irf6MO do not effectively block
maternal Irf6 expression because Irf6 protein is translated in the
oocyte, as has been proposed to explain the limited effectiveness of
MO targeting other maternal transcripts (Bruce et al., 2003).
We reasoned that the function of maternally-expressed Irf6 might
be blocked by injection of RNA encoding a dominant inhibitory Irf6
protein. To create such a reagent, we engineered D. rerio irf6 cDNA to
encode solely the amino-terminal 115 amino acids, containing the
presumed DNA binding domain (Irf6DBD) (Fig. 2C, Kondo et al., 2002a).
Preliminary gel shift experimentswith human IRF6DBD indicated that it
indeed binds a subset of previously identiﬁed Interferon Stimulated
Regulatory Elements (BCS, unpublished ﬁndings). Injection of a high
dose (3 ng) of irf6DBD mRNA into 1-cell stage embryos led to death,
with embryonic disintegration, by 90% epiboly (Fig. 2D) (82% affected,
n=55). Importantly, co-injection of 3 ng of irf6 mRNA (irf6ORF) was
able to partially rescue the phenotype of death at gastrulation, arguing
for speciﬁcity of Irf6DBD (Fig. 2E, 24% affected, n=70). Embryos injected
with 3 ng of irf6ORF RNA alone underwent gastrulation normally (not
shown). A fraction of embryos injected with a lower dose of irf6DBD
mRNA survived gastrulation and at 3 days post fertilization (dpf)
displayed short pectoral ﬁns and blistered skin (Fig. 2G) (19%, n=36). In
these embryos, cartilage elements of the craniofacial skeleton are
present but reduced in size and variably disorganized (Fig. 2H and not
shown). Of note, these phenotypes are reminiscent of the truncated
forelimbs, abnormal skin, and disorganized craniofacial skeleton ofmice
deﬁcient for Irf6 (Ingraham et al., 2006; Richardson et al., 2006). These
results suggest that maternally-expressed Irf6 is necessary during
epiboly inD. rerio embryos. However it is possible that the relevant Irf6-
type activity is instead provided by an Irf6 homologue whose activity is
inhibited by Irf6DBD. We provide evidence in favor of the ﬁrst model
later in this work.
Irf6 is required for epiboly of all three cell layers
In D. rerio, gastrulation movements include epiboly, internaliza-
tion, and convergence and extension (Solnica-Krezel, 2006). During
epiboly the three cell layers of D. rerio blastula, i.e. the deep layer
(DEL), the enveloping layer (EVL), and the yolk syncytial layer (YSL),
undergo characteristic behaviors, and the motions of these layers can
be affected differentially in mutants. For instance, in the ecadmutant,
epiboly of the DEL is primarily affected (Kane et al., 1996; McFarland et
al., 2005), while in poky mutants, epiboly of all three layers is slower
than normal (Wagner et al., 2004) (molecular characterization of the
poky locus has not yet been reported). We sought to assess which
layers were affected in irf6DBD-injected embryos. In control embryosat 80% epiboly stage (8.3 hpf), the DEL thinned to just a few layers
thick (Fig. 2D and Supplemental movie) (behavior of DEL cells during
epiboly described in Kane et al., 2005). However, in irf6DBD-injected
embryos from the same clutch, thinning of the DEL stopped at
approximately dome stage (4.3 hpf) (Fig. 2D panels and Supplemental
movie). The upward doming of the yolk, caused by YSL migration, was
profoundly delayed and asymmetric in irf6DBD-injected animals (Fig.
2D and Supplemental movie). To aid in visualization of EVL cells, we
stained embryos to reveal expression of a keratin 8 homologue, zfk8
(Imboden et al., 1997). In irf6DBD-injected embryos the number of
zfk8 expressing cells is highly reduced (discussed below), but the
leading edge of the EVL is still discernible and does not extend past the
position found in control embryos at about sphere stage (4.3 hpf)
(Figs. 2J, K). To monitor YSL migration we labeled YSL nuclei by
injecting SYTOX green into the yolk (D'Amico and Cooper, 2001).
When uninjected sibling embryos were at 75% epiboly stage, YSL
nuclei in irf6DBD-injected embryos remained at the margin adjacent
to the DEL cells (88% affected, n=16) (Figs. 2L, M). Ultimately, when
control embryos are at approximately 90% epiboly, irf6DBD-injected
embryos rupture near the animal pole and cells spill out (82% affected,
n=55) (Fig. 2D and Supplemental movie). Thus, morphogenesis of all
three cell layers is affected in irf6DBD-injected embryos, similar to the
maternal effect mutant poky (Wagner et al., 2004).
Markers of EVL are lost in irf6DBD-injected embryos
The rupture of irf6DBD-injected embryos during epiboly suggests a
failure of EVL integrity. To explore this further, we examined
expression of zfk8 (Imboden et al., 1997), a keratin18 orthologue
(krt18) (Pei et al., 2007), a keratin 4 orthologue (k4) (Pei et al., 2007),
and CCAAT/enhancer binding protein, beta (cebpb) (Lyons et al., 2001).
These genes are strongly expressed in EVL of uninjected control
embryos at 50% epiboly (Figs. 3A, C, E, and not shown). In irf6DBD-
injected embryos at 50% epiboly, the normally continuous expression
of these genes becomes patchy and, in strongly affected embryos, is
almost absent (Figs. 2K, 3B, D, F, and not shown) (for all panels in Fig. 3,
≥60% affected, n≥25). EVL cells in control embryos at 50% epiboly are
characterized by a cortical ring of ﬁlamentous actin (F-actin) revealed
by phalloidin stain (Fig. 3G) (Koppen et al., 2006). In high-dose
irf6DBD-injected embryos this pattern is lost, with phalloidin stain in
superﬁcial cells either diffuse or absent (Fig. 3H).
We sought to determine if there was abnormal gene expression in
other cell layers. The DEL is composed of epiblast, which will give rise
to neural and non-neural ectoderm, and hypoblast, which will give
rise to mesoderm and endoderm (Warga and Kimmel, 1990). At 60%
epiboly gata2 and tfap2a are expressed in non-neural epiblast (Figs. 3I,
K), and sox2 is expressed in neural epiblast (Fig. 3M). In irf6DBD-
injected embryos, when control sibling embryos have reached 60%
epiboly, gata2 and sox2 are expressed at high levels on one side of the
embryo (Figs. 3J, N), but tfap2a expression is markedly reduced (Fig.
3L). It possible the differential effect on tfap2a reﬂects overall delay in
irf6DBD-injected embryos, because tfap2a initiates expression later
than gata2 (RAC unpublished). Expression of the pan-hypoblast
marker ntl is comparable in control and irf6DBD-injected (Figs. 3O,
P), implying no defect in hypoblast induction. However, in irf6DBD-
injected embryos, expression of gsc in dorsal hypoblast, the shield,
was expanded to a larger arc, suggesting reduced convergence
movements in the hypoblast (Figs. 3Q, R). Thus in irf6DBD-injected
embryos we observed strong reduction in levels of four makers of the
EVL, while we detected evidence of developmental delay but not of
gross mispatterning of the DEL.
Effect of irf6DBD on cell survival
To determine if epiboly arrest in irf6DBD-injected embryos
reﬂected a role for Irf6 in cell survival, we assessed apoptosis. At
Fig. 3. Irf6DBD-mediated changes in gene expression in shield-stage D. rerio embryos. Dorsal views, except as indicated, of uninjected and irf6DBD-injected embryos, as indicated by
the column header, ﬁxed when uninjected sibling embryos reached shield stage. Embryos processed for in situ hybridization to reveal expression of the indicated gene, except as
noted. Images portray the phenotype displayed by 60%–80% of embryos in the experimental group, n=25 embryos or greater. (A–F) Expression of zfk8, krt18, and cebpb, are expressed
in all EVL cells of uninjected embryos but absent in large patches in uninjected embryos. (G) Uninjected and, (H) irf6DBD-injected embryos stained with phalloidin, revealing
polymerized actin (i.e., F-actin). (G) In the uninjected embryo, F-actin is visible in a cortical ring within every EVL cell. (H) In the irf6DBD-injected embryo, there is loss (⁎) or
disorganization of F-actin in superﬁcial cells. (I, J) Lateral views, showing gata2 expression in non-neural epiblast is present but displaced the irf6DBD-injected embryo. (K, L) In
contrast to gata2, expression of tfap2a, a marker of non-neural epiblast, is highly reduced in the irf6DBD-injected embryo. (M,N) sox2 expression, a marker of neural epiblast, is
present in the irf6DBD-injected embryo. (O, P) Lateral views, showing that ntl expression, a marker of hypoblast, is present in the irf6DBD-injected embryo. (Q, R) gsc expression is
present in the shield hypoblast of the uninjected embryo, and in an expanded arc in the irf6DBD-injected embryo, consistent with developmental delay in the latter (arrowheads
show extent of gsc expression arc). (S, T) Lateral views of embryos processed to reveal cells undergoing apoptosis by TUNEL. TUNEL-positive cells are absent from this uninjected
embryo. In the irf6DBD-injected embryo, many TUNEL-positive cells are visible, primarily within the EVL.
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cells (0% with N5 TUNEL-positive cells, n=55; Fig. 3S), while high-dose
irf6DBD-injected embryos ﬁxed at the same time had many TUNEL-
positive cells (100% with ≥5 TUNEL-positive cell, n=45), most
prominently in the EVL (Fig. 3T). Because cell death pathways are
not active in D. rerio until 7 hpf (Ikegami et al., 1999) but Irf6DBD-
injected embryos appear to stall at about 4.3 hpf, we doubted that
control of cell survival was the principle function of Irf6. To test this
prediction, we co-injected embryos with p53 MO and high-doseirf6DBD mRNA. We processed a portion of these embryos at 90%
epiboly and observed that the number of TUNEL-positive cells was
highly reduced (0% with ≥5 TUNEL-positive cells, n=42). However, the
majority of the remaining embryos ruptured at around 90% epiboly
(84%, n=40), and had reduced k4 expression (95% n=22). Together
these results argue against the possibility that loss of gene expression
in the EVL in Irf6DBD results from such cells entering a cell death
pathway; instead they suggest Irf6 directly regulates EVL cell
differentiation.
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To determine whether loss of gene expression in the EVL of
irf6DBD-injected embryos reﬂected a cell-autonomous requirement of
Irf6 in the EVL, we generated cDNA encoding Irf6DBD with a Myc-
epitope tag at the C-terminal end (irf6DBD-MT). Embryos injected at
the 1-cell stagewith irf6DBD-MTmRNAdisplayed the same phenotype
as embryos injected with irf6DBD (data not shown). We injected
irf6DBD-MTmRNA into one blastomere of 16-cell stage embryos, ﬁxed
the embryos at 70% epiboly, and processed them to reveal zfk8 and
anti-Myc immunoreactivity (IR). EVL cells with prominent nuclear
anti-Myc IR did not express zfk8, although adjacent cells did (Fig. 4A).
These results imply a cell-autonomous function of Irf6 within EVL
cells.
Because Irf6DBD blocks epiboly, and epiboly requires the YSL, we
tested for a cell-autonomous requirement for Irf6 in the YSL. We
injected irf6DBD mRNA and SYTOX green either into 1-cell stage
embryos or into the yolk after the sphere stage (4 hpf) (D'Amico and
Cooper, 2001). Embryos injected at the 1-cell stage almost all died by
90% epiboly (88%, n=16) as expected; by contrast, the embryos with
YSL-targeted injections developed with normal YSL migration and
normal morphology (86%, n=28) (Figs. 4B, C). These ﬁndings argue
against a cell-autonomous requirement for Irf6 activity in the YSL,
although an important caveat is that mRNA injected at sphere stage
has less time to be translated prior to epiboly than RNA injected into
early blastomeres.
Identiﬁcation and characterization of Xenopus Irf6 genes
The strong effect of Irf6DBD in D. rerio, along with the lack of effect
using irf6 MOs and the presence of maternal irf6 mRNA, all suggested
that the Irf6DBD interferes with DNA binding of the maternal pool of
Irf6 protein. Alternatively, Irf6DBD might block the activity of one or
more Irf6-related proteins. To distinguish these models, we turned toFig. 4. The Irf6DBD effect is cell autonomous to the EVL. (A) Animal pole view of an
embryo injected with irf6DBD-MT mRNA into a single blastocyst at 16–32 cell stage,
processed at shield stage for zfk8 mRNA (purple) and anti-cMyc IR (brown). Superﬁcial
cells which contain anti-Myc IR (arrowheads) have highly reduced zfk8 expression in
comparison to cells that do not contain anti-Myc IR (⁎). (6 cells clearly containing
nuclear anti-Myc IR and also clearly in the same plane at the EVL observed in 3 embryos,
0/6 displayed detectable zfk8 signal). (B, C) Lateral views of embryos at shield stage
which had been injected with (B) SYTOX green or (C) SYTOX green and irf6DBD into the
yolk at sphere stage (4 hpf). There is normal progression of epiboly of yolk syncytial
nuclei in both embryos.another vertebrate model, X. laevis, where it is possible to deplete
maternal stores of mRNA (Heasman et al., 1991). In X. laevis, we
identiﬁed two irf6 ESTs that share 92% identity at the nucleotide level
(irf6.1 and irf6.2) (Hatada et al., 1997; Klein et al., 2002). Although
these transcripts may represent different alleles of irf6 or separate
paralogues, two irf6 paralogues are present in the sequenced genome
of a related species, X. tropicalis (DWH, unpublished observations),
providing evidence for the latter possibility. A previous study in X.
laevis showed that irf6 (irf6.1) was maternally expressed, with later
expression surrounding the blastopore and in the tailbud blastema
(Hatada et al., 1997). Using primers speciﬁc for irf6.2 we detected
maternal and zygotic expression by RT-PCR (Fig. 5A), and using a
probe derived from irf6.2, we detected a pattern similar to that
reported for irf6.1 (Figs. 5B–G). Because irf6.1 and irf6.2 probes may
cross-hybridize, this pattern likely represents a combination of the
expression of both genes. Alternatively, irf6.1 and irf6.2 may have
identical expression patterns. The pattern of irf6 expression in X. laevis
shares many similarities with irf6 expression in D. rerio, including
prominent expression at gastrula stage, in the otic vesicle and in facial
epithelium.
Because blocking Irf6 function in D. rerio caused EVL defects, we
more closely examined irf6 expression in the SE and deep layers of
early X. laevis embryos. We performed in situ hybridization for irf6 on
sectioned late blastulae and found expression in both layers (Fig. 5I).
These datawere conﬁrmed by quantitative RT-PCR, using RNA isolated
from explanted superﬁcial and deep epithelial layers. Levels of irf6
were similar in the two layers, whereas a marker of the superﬁcial
layer, enhancer of split related 6-epidermis (esr6e, Deblandre et al.,
1999) was detected only in the SE layer (Fig. 5J). Thus, irf6 is not
restricted to speciﬁc layers of the early ectoderm, at least at the level of
mRNA expression, which is consistent with the inheritance of irf6
transcripts from the egg.
Injection of irf6DBD and depletion of maternal Irf6 disrupt SE formation
in Xenopus
We found that injection of the D. rerio irf6DBDmRNA into X. laevis
embryos caused exogastrulation and eventual rupture of the embryo
near the animal pole, consistent with a possible defect in the
superﬁcial epithelium (Figs. 6D, F). Supporting this possibility, by
RT-PCR we detected greatly reduced expression of esr6e, a marker of
the superﬁcial epithelium, in animal explants harvested from X. laevis
embryos injected with irf6DBD. A second marker, grainyhead-like 3
(grhl3), is normally expressed at higher levels in the SE than in DEL
(Fig. 6G, Chalmers et al., 2006). We found that expression ghrl3 was
reduced but not absent in animal explants from irf6DBD-injected
embryos, and by separating SE and deep blastomere layers we
observed that ghrl3 expression is preferentially lost from the SE of
such explants (Fig. 6G). Of note, SE layers isolated from irf6DBD
injected embryos could be cultured for 24 h without disintegration or
signs of widespread cell death, which are easily recognized (Hensey
and Gautier, 1997). This suggests that cell death is unlikely to be the
primary cause of loss of gene expression characteristic of the SE. Thus,
in X. laevis as in D. rerio, Irf6DBD inhibits development of the
superﬁcial epithelium, suggesting a conserved requirement for Irf6 in
simple epithelial formation.
To further test whether inhibition of maternally-encoded Irf6 was
sufﬁcient to disrupt superﬁcial epithelium formation, we blocked the
translation of maternal irf6 transcripts in X. laevis oocytes with a
morpholino (MO) designed to complement both irf6.1 and irf6.2
transcripts (see Methods). We harvested oocytes, injected them with
24 ng of irf6 MO, and cultured them in vitro for 24 h (Heasman et al.,
1991). We then matured the oocytes with progesterone, transferred
them into the body cavity of egg-laying host females, and fertilized the
resulting eggs to generate Irf6-depleted embryos. Depleted embryos
developed normally through cleavage and blastula stages, but were
Fig. 5. Expression of irf6 in Xenopus laevis. (A) RT-PCR analysis of irf6 expression at different stages of development. Developmental stages are indicated at the top (Nieuwkoop and
Faber, 1956). −RT, negative control reaction without reverse transcriptase. (B–G) Whole mount in situ hybridization for irf6. (B) Stage 10.5, left is vegetal view, arrow indicates
expression in the dorsal marginal zone. Right is animal pole view. (C) Stage 11, expression is throughout marginal zone, but beginning to be lost from dorsal midline. (D) Stage 12.5,
expression around blastopore, absent from prospective notochord. (E) Stage 18, expression ﬂanking prospective tailbud region, arrow. (F) Stage 28 and (G) stage 30, notable
expression in tailbud, arrowheads. (H) Section of animal cap hybridized with an irrelevant control probe (xnr3). (I) Section of animal cap hybridized with an antisense irf6 probe.
Diffuse expression is found in both superﬁcial and deep layers. (J) Quantitative RT-PCR of irf6 (green) and esr6e (blue) expression in ectodermal explants; st. 10 (stage 10 whole
embryo), DEL (deep layer explant), SE (superﬁcial layer explant).
Fig. 6. Defects in development of superﬁcial epithelium in irf6DBD-injected X. laevis embryos. (A) Animal and, (C) vegetal views of stage 11 uninjected controls (Un). (B) Animal and
(D) vegetal views of stage 11 embryos injected with 2 ng D. rerio irf6DBD mRNA. (E) Uninjected (Un) and (F) irf6DBD-injected stage 14 embryos. Arrow in (F) indicates lesion in the
ectoderm. (G) RT-PCR analysis of SE markers, esr6e and grhl3 in control (Un) and irf6DBD-injected embryos and explants. St.11, whole embryo stage 11; cap, stage 11 animal cap; DEL,
deep layer explants; SE, superﬁcial layer explants.
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258 J.L. Sabel et al. / Developmental Biology 325 (2009) 249–262delayed in gastrulation and formed open blastopores (Fig. 7A, right
hand embryos), closely resembling X. laevis embryos injected with
irf6DBD (Fig. 6B). Irf6-depleted embryos failed to elongate fully and
subsequently developed epidermal lesions (Fig. 7B, right hand
embryos; 90% affected, n=50). Like irf6DBD-injected embryos, irf6-
depleted embryos lacked visible heads (discussed further below).
Interestingly, fertilized eggs injectedwith the same dose ofMO (24 ng)
developed normally, with a minor proportion showing blastopore
closure defects (Figs. 7C–D, 5% affected, n=30). The contrast in the
effects of Irf6 depletion before and after fertilization strongly suggests
that the maternal store of Irf6 that is critical for normal early
development.
To test for alterations in SE fate in maternal irf6-depleted embryos,
we analyzed the expression of SE markers, esr6e and grainyhead-like-3
(grhl3), as well as a deep layer marker, sox11, over several gastrula
stages by quantitative RT-PCR (Chalmers et al., 2002, 2006). Expres-
sion of esr6ewas nearly eliminated in Irf6-depleted embryos (Fig. 7E).
Whereas grhl3 was unaffected at early gastrula stages, it was reduced
to 25% of control levels by midgastrula stage (stage 11) (Fig. 7E). In
embryos where irf6 MO was injected after fertilization, esr6e was
reduced to 50% of control levels at stage 11, and grhl3 was unaffected,
reﬂecting the reduced effectiveness of this depletionmethod (data not
shown). By contrast, levels of the deep layer marker sox11 in whole
embryos were not signiﬁcantly different from controls (Fig. 7E).
Additionally, irf6 levels were not greatly altered, indicating a lack of
compensatory regulation (Fig. 7E). Expression of the presumptive
neural precursor marker sox2, the mesodermal marker xbra, and two
organizer markers (nodal related 3 and goosecoid) (not shown) were
also not severely affected (Fig. 7E and not shown). SE layers isolatedFig. 7.Maternal Irf6 is required for SE speciﬁcation in X. laevis. (A) Control (left side) and Irf6
animal view. (B) Control (left embryo) and Irf6-depleted (right four embryos) embryos a
uninjected embryos. (D) embryos injected with 24 ng irf6MO at the 1–2 cell stage. (E) Quant
(Un) and Irf6-depleted embryos (irf6 MO) at the indicated stages. Graphs represent data frofrom Irf6-depleted embryos could be cultured for 24 h without
disintegration or signs of widespread cell death (not shown),
suggesting the loss of SE markers is not due to loss of the cells
themselves. These results suggest that defects in Irf6-depleted
embryos during gastrula stages are primarily within the SE layer.
The later defects in these embryos, including anterior defects, most
likely result from abnormal morphogenesis.
Consistent with reduced expression of early SE markers in Irf6-
depleted tissue, we observed reduced expression of markers of cell
types that are derived from the SE. Control and Irf6-depleted embryos
were analyzed by whole-mount in situ hybridization for intelectin 2
(intel2), a marker of SE-derived mucosecretory cells (Hayes et al.,
2007). We also stained sections from control and Irf6-depleted
embryos with the monoclonal antibody LP3K, which was raised
against mouse cytokeratins and labels the apical surface of SE cells
(Lane et al., 1985). In control embryos at stage 14, intel2 robustly
labeled cells in the SE layer and LP3K stained the surface of the
superﬁcial epithelium (10/10 cases each; Figs. 8A, C). In sibling Irf6-
depleted embryos, intel2 and LP3K staining were absent (0/10
embryos each; Figs. 8B, D). We further assessed overall development
of pre-larval skin in tailbud stage embryos by histological staining.
Azan staining of control embryos showed thinned ectodermal layers
with apically localized embryonic pigment granules, a hallmark of
mature epidermis (3/3 cases; Fig. 8E) (Nieuwkoop and Faber, 1956).
Irf6-depleted embryos at this stage displayed thicker than normal
epidermis with basally localized pigment granules (3/3 cases; Fig. 8F),
suggesting that the epidermis is in a less differentiated state than the
controls. These results demonstrate that maternal Irf6 is necessary for
the normal differentiation of superﬁcial epithelial cells in Xenopus.-depleted (right side) embryos at stage 12. Upper row is a vegetal view; lower row is an
t stage 24. Arrow indicates epidermal lesion in an Irf6-depleted embryo. (C) Control
itative RT-PCR of esr6e, grhl3, sox11, irf6, sox2 and xbra expression in uninjected embryos
m a single PCR run.
Fig. 8.Maternal Irf6 is required for SE differentiation in X. laevis. (A, B) Whole mount in
situ hybridization of stage 14, control (A) uninjected (Un) and (B) Irf6-depleted (irf6MO)
embryos for intelectin 2 (intel2). Lateral view is shown, anterior is to the left. Inset shows
close up views of the epidermis in a bisected embryo. (C, D) Sections of (C) uninjected
and (D) Irf6-depleted stage 13 embryos stained with mAb LP3K. (E, F) Sections of, (E)
control and, (F) Irf6-depleted stage 22 embryos stained with Azan. Dotted lines indicate
the thickness of the ectoderm; arrows indicate the location of embryonic pigment.
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To conﬁrm the speciﬁcity of phenotypes seen in Irf6-depleted
embryos, we performed rescue experiments using an irf6.2 mRNA
lacking the full MO-binding sequence. MO-injected oocytes were
cultured for 24 h and then injected with irf6.2mRNA, fertilized by host
transfer and analyzed. Interestingly, injection of a wide range of irf6
mRNA amounts, from 20 pg to 500 pg, into Irf6-depleted embryos,
exacerbated the embryonic phenotype rather than rescuing it (data
not shown). However, in RT-PCR analysis of gastrula stage embryos,
injection of 50 pg of X. laevis irf6.2 mRNA partially reversed theFig. 9. Speciﬁcity of Irf6 depletion in Xenopus. (A) Quantitative RT-PCR of esr6e and grhl3 expr
with 50 pg irf6.2mRNA (MO+RNA), or (B) with 250 pg irf6.2mRNA (MO+RNA). (C– E) Whol
Irf6-depleted (irf6 MO) and (E) rescued embryos (irf6 MO+ irf6 RNA).inhibition of esr6e and grhl3 expression (Fig. 9A), suggesting that the
effects of irf6MO injection are indeed speciﬁc to the depletion of Irf6.
In separate experiments, injection of a higher dose (250 pg) of irf6.2
mRNA was able to almost completely rescue esr6e and grhl3
expression (Fig. 9B), but was also unable to rescue the exogastrulation
phenotype (data not shown). We also assessed the degree of rescue in
whole embryos by in situ hybridization for intel2 expression. Controls
robustly expressed intel2 at stage 14 (8/8; Fig. 9C), and expressionwas
eliminated in Irf6-depleted embryos (0/8; Fig. 9D). However, patches
of intel2-expressing cells were evident in a subset of Irf6-depleted
embryos injected with irf6 (2/8 with patchy expression; Fig. 9E), even
though the embryo morphology was grossly abnormal. Thus, these
instances of partial rescue provide evidence that the effects of MO
injection are due to inhibition of Irf6. They further suggest that levels
of Irf6 activity must be precisely controlled for normal development to
occur.
Discussion
Irf6 depleted embryos die at gastrula stage
These ﬁndings suggest that an Irf6-like activity is required for
gastrulation in D. rerio and X. laevis, and several lines of evidence
indicate that this activity is provided bymaternally-encoded Irf6. First,
maternal irf6 mRNA is readily detected by RT-PCR or in situ
hybridization in both organisms. Second, injection of antisense MO
after fertilization, which should target zygotic irf6 transcripts
efﬁciently but maternal ones less well or not at all, does not affect
gastrulation in either species. Third, forced expression of Irf6DBD
causes D. rerio and X. laevis embryos to stall in epiboly. The effect of
Irf6DBD in both species is partially rescued by co-injection of RNA
encoding full-length Irf6. The simplest interpretation of these ﬁndings
is that maternal irf6 transcripts are translated too early to be
effectively targeted by MO, while maternal Irf6 protein is displaced
from its normal chromatin binding sites by Irf6DBD. However, X. laevis
embryos derived from oocytes injected with irf6 MO display a
phenotype that is remarkably similar to embryos injected with
irf6DBD. Thus maternal Irf6 protein may largely substitute for the
loss of zygotic Irf6, at least over the period when morpholinos are
effective. While most maternally supplied mRNAs are degraded prioression in controls (Un), Irf6-depleted embryos (irf6MO) and depleted embryos injected
e mount in situ hybridization for intelectin 2 at stage 14, (C) control uninjected (Un), (D)
260 J.L. Sabel et al. / Developmental Biology 325 (2009) 249–262to or about the time of the mid-blastula transition, a microarray study
identiﬁed 142 maternal transcripts that are stable until segmentation
stages and beyond (Mathavan et al., 2005). Moreover, many maternal-
effect mutants have been isolated whose phenotype is not discernible
until after zygotic transcription begins, and one such mutant, polly-
wog, appears to develop normally until at least 10 hpf (Wagner et al.,
2004). It is an intriguing possibility that there is a role for maternal Irf6
in mammals, perhaps in formation of the trophectoderm. Unfortu-
nately, this possibility cannot be readily tested because mouse Irf6 null
mutants die shortly after birth (Ingraham et al., 2006; Richardson et
al., 2006), precluding examination of pups derived from Irf6 null
females.
An alternative model consistent with these data is that there is an
Irf6 homologue whose binding to DNA is inhibited by Irf6DBD. Indeed,
given the profound defects in skin and limb development in mouse
Irf6 mutant embryos (Ingraham et al., 2006; Richardson et al., 2006),
we were surprised that defects did not emerge in post-gastrula stage
D. rerio embryos that had been injected with splice-blocking irf6 MO.
In addition, the observation that embryos derived from irf6-MO-
injected oocytes have a less severe phenotype than embryos injected
with Irf6DBD is consistent with the possibility that Irf6DBD interferes
with activity of a protein other than Irf6 (although the difference may
reﬂect incomplete knockdown of Irf6 levels in MO-injected oocytes).
In teleost ﬁshes there are duplicated copies of many genes that are
present in single copy in mammals (Postlethwait et al., 1998).
However, our database searches yielded only a single D. rerio irf6
orthologue, on chromosome 22. The most closely related gene is a
clear irf5 orthologue on chromosome 4 (peptide sequence is 46%
identical/60% similar).Whilewe detect expression of irf5 at embryonic
stages, our preliminary double knock down experiments did not
support the model that Irf5 and Irf6 act coordinately (J.S., C.d'A. and
RAC, unpublished observations). At this point we cannot rule out the
possibility of redundant activity of an Irf6 homologue, sensitive to
inhibition by Ird6DBD, during early development in D. rerio. Creation
of maternal-zygotic irf6 null mutant embryos, which may be possible
in D. rerio (Ciruna et al., 2002; Doyon et al., 2008; Meng et al., 2008),
would allow deﬁnitive resolution of these models.
Why do irf6DBD-injected D. rerio embryos stall in epiboly?
Experiments conducted in Fundulus and D. rerio suggest the engines
driving epiboly include microtubule-dependent vegetal migration of
the YSL, which pulls the ﬁrmly-attached EVL behind it (Betchaku and
Trinkaus, 1978; Solnica-Krezel, 2006), contraction of microtubules at
the margin (Strahle and Jesuthasan, 1993), and possibly actively
crawling behavior of leading-edge EVL cells (Keller and Trinkaus,
1987; Zalik et al., 1999). Epiboly movements of the YSL are blocked in
Irf6DBD injected animals. It is unclear whether this reﬂects a cell
autonomous requirement for Irf6 within the YSL, however our ﬁnding
that injection of irf6DBD mRNA into the YSL at 2 hpf has no effect on
epiboly does not support this possibility. There is high level expression
of irf6 in dorsal forerunner cells (DFC), a cluster of ingressing EVL cells
present just vegetal to the shield (Cooper and D'Amico, 1996; Oteiza et
al., 2008). Perhaps failure of epiboly in irf6DBD-injected embryos in
part reﬂects loss of a DFC-mediated role in epiboly. However, any such
role is presumably conﬁned to the dorsal side of the embryo, while
Irf6DBD appears to block epiboly at all radial positions. Instead, we
favor the model that a cell-autonomous requirement for Irf6 in the
EVL largely or entirely accounts for the stall in epiboly of irf6DBD-
injected D. rerio embryos. There is precedent for such a possibility,
because knockdown of a set of keratin genes expressed only in EVL
prevents epiboly in D. rerio (Pei et al., 2007), and depletion of maternal
ker8 disrupts gastrulation in X. laevis (Torpey et al., 1992). We envision
that in irf6DBD-injected animals, as in normal embryos, a vegetal-pole
directed force is generated in the YSL by microtubule-based mechan-
isms (Solnica-Krezel and Driever, 1994; Strahle and Jesuthasan, 1993).
When this force is transmitted to the EVL, the abnormal differentiation
of EVL cells prevent them from spreading during epiboly. Conse-quently, force builds up until the EVL ruptures and deep cells spill out.
In X. laevis embryos, epiboly is driven by outward radial intercalation
of deep blastomeres, although not into the superﬁcial epithelium
(Keller, 1980). Similar to the model for D. rerio, exogastrulation in Irf6-
depleted X. laevis embryos may reﬂect a loss of mechanical strength in
the superﬁcial epithelium.
Irf6 governs differentiation of epithelial tissues
These present results extend earlier studies indicating that Irf6 is
required for differentiation of a stratiﬁed epithelium. In D. rerio
embryos and X. laevis embryos with reduced Irf6, all epithelial
features of the PSE analyzed were lost, and a mosaic experiment
indicates the requirement for Irf6 is cell autonomous to the PSE.
However, the principle function of Irf6 in superﬁcial epithelial cells is
unclear. It is possible that the primary requirement for Irf6 is to
maintain cell adhesiveness between PSE cells, because expression of
simple epithelium keratins in PSE depends on cell contact (Jones and
Woodland, 1986; Sagerstrom et al., 2005). Could the primary function
of Irf6 be to promote survival of PSE cells? We feel this is unlikely
because previous studies have shown treating embryos with inducers
of apoptosis (gamma irradiation, camptothecin, alpha-amanitin) does
not result in cell death until 7 hpf in D. rerio (Ikegami et al., 1999) and
stage 10.5 in X. laevis (Hensey and Gautier, 1997). This critical period is
later than the time that we detect changes in gene expression or
morphology in Irf6 knockdown embryos. Moreover, reagents that
block cell death induced by Irf6DBD, neither prevented the morpho-
logical phenotype nor the loss of expression of an EVLmarker. It is also
possible that Irf6 governs speciﬁcation of PSE cells. A prediction of this
model is that superﬁcial cells deprived of Irf6 will be competent to join
the deep layer; experiments to test this prediction are underway. The
strongest conclusion from the present data is that Irf6 is required for
superﬁcial cells to adopt simple epithelial architecture (i.e. simple
squamous in the case of D. rerio PSE and simple cuboidal in X. laevis
PSE). This adds to evidence that Irf6 promotes exit from the cell cycle
and differentiation of keratinocytes (Ingraham et al., 2006; Richardson
et al., 2006) and breast epithelium (Bailey et al., 2008a,b).
The Irf6 regulatory pathway governing PSE development
Which gene products act in concert with Irf6 to promote PSE
development? Excellent candidates are those that, like Irf6, have been
implicated in differentiation of epidermal keratinocytes, including AP-
2 family members (Guttormsen et al., 2008; Wang et al., 2006), p63
(Truong and Khavari, 2007), Ikka (Hu et al., 1999; Li et al., 1999), 14-3-
3sigma (Li et al., 2005), and aPKC (Helfrich et al., 2007). aPKC is an
especially intriguing candidate because not only is it required for
differentiation of basal keratinocytes in mouse (Helfrich et al., 2007),
aPKC is sufﬁcient to upregulate expression of SE layer markers in deep
layer cells (Ossipova et al., 2007), similar to knock down of Irf6.
Activity of other IRF family members is stimulated by phosphorylation
(reviewed in Paun and Pitha, 2007), and Irf6 is regulated by
phosphorylation in breast epithelium (Bailey et al., 2005). An
interesting avenue for future work will be to test whether Irf6 is
directly activated by aPKC-mediated phosphorylation. Which genes
act downstream of Irf6? Loss of adhesion among X. laevis blastomeres
is observed upon misexpression of the small GTPases Rac, Cdc42, and
Rnd1 (Choi and Han, 2002; Hens et al., 2002; Wunnenberg-Stapleton
et al., 1999) and also after disruption of p21-activated kinase (PAK)
(Faure et al., 2005); genes encoding these proteins are all potential
targets of Irf6. In irf6DBD-injected embryos, EVL cells lack the cortical
band of F-actin normally associated with adherens junctions (Naga-
fuchi, 2001). In D. rerio embryos, disruption of actin-polymerization
with cytochalasin D causes a phenotype of embryonic rupture that is
morphologically indistinguishable to that observed in irf6DBD-
injected embryos (Zalik et al., 1999). Moreover, in X. laevis embryos,
261J.L. Sabel et al. / Developmental Biology 325 (2009) 249–262cytochalasin D blocks expression of an epidermal marker and the cell
cycle (Jones andWoodland, 1986). Thus, crucial transcriptional targets
of Irf6 in PSE cells may include genes that govern organization of actin
into ﬁlaments, of which a large number are known (Uribe and Jay, in
press). Finally, genes disrupted in D. rerio maternal-effect mutants
with abnormal epiboly are intriguing candidates for members of the
Irf6 regulatory pathway (Wagner et al., 2004).
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